Gross Margin: A company's total sales revenue minus its cost of goods sold, divided by the total sales revenue, expressed as a percentage. Calculated as: Gross Income / Total Revenues
Adaptive Biotechnologies Corporation (ADPT) had Gross Margin of 74.58% for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$71.68M |
|
$-13.58M |
|
$18.22M |
|
$53.46M |
|
$84.45M |
|
$-12.77M |
|
$-0.81M |
|
$-13.58M |
|
$-13.58M |
|
$-13.58M |
|
$-13.58M |
|
$-13.58M |
|
$-13.58M |
|
$-12.77M |
|
$-8.87M |
|
151.72M |
|
151.72M |
|
$-0.08 |
|
$-0.08 |
|
| Balance Sheet Financials | |
$300.19M |
|
$34.11M |
|
$212.55M |
|
$512.74M |
|
$89.92M |
|
-- |
|
$197.82M |
|
$287.74M |
|
$225.00M |
|
$104.30M |
|
$225.00M |
|
153.78M |
|
| Cash Flow Statement Financials | |
$-45.99M |
|
$37.95M |
|
$30.40M |
|
$50.82M |
|
$73.18M |
|
$22.37M |
|
$51.48M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.34 |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
Gross Margin |
74.58% |
-17.82% |
|
-17.82% |
|
-- |
|
-18.94% |
|
-18.94% |
|
$-48.95M |
|
-- |
|
-- |
|
-- |
|
0.14 |
|
1.86 |
|
1.42 |
|
63.24 |
|
-6.04% |
|
-13.02% |
|
-2.65% |
|
-6.04% |
|
$1.46 |
|
$-0.32 |
|
$-0.30 |
|